Cadence Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Cadence Bank’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21,800	Closed	-$51K	–	259
2018 Q2	$51K	Hold	21,800	–	–	﹤0.01%	240
2018 Q1	$64K	Hold	21,800	–	–	0.01%	241
2017 Q4	$60K	Buy	+21,800	New	+$67K	0.01%	253

Other funds holding PDLI

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Cadence Bank's PDLI Position: Q3 2018 in Review

Cadence Bank sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 21,800 shares — an estimated $51K sold.

Cadence Bank first reported a position in PDLI in Q4 2017 and held it in 3 quarters. The position peaked at $64K in Q1 2018. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

Cadence Bank reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
Cadence Bank sold 21,800 PDL BioPharma, Inc. shares in Q3 2018, an estimated $51K.
Cadence Bank first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 3 quarters.
Cadence Bank's PDL BioPharma, Inc. position peaked at $64K in Q1 2018.
152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on Cadence Bank's 13F filing for Q3 2018, filed 25 Oct 2018.